Robert E. Latta

03/18/2026 | Press release | Distributed by Public on 03/18/2026 14:16

Latta Introduces STOP Nitazenes Act to Combat Rising Synthetic Opioid Deaths

Today, Congressman Bob Latta (OH-5) introduced the Strengthening Tools to Outlaw Poisonous (STOP) Nitazenes Act, a bill to permanently schedule 2-benzylbenzimidazole opioids, commonly known as nitazenes, as Schedule I controlled substances. Fatal overdoses continue to rise across the United States, and nitazenes, a dangerous class of illicit synthetic opioids, are increasingly contributing to overdose deaths nationwide.

"Families in Ohio and across the nation have already felt the devastating impact of the ongoing fentanyl crisis. With the rise in nitazene use, the opioid epidemic is becoming even more dangerous. That's why I introduced the Stop Nitazenes Act, to permanently classify nitazenes as a Schedule 1 drug, the most restrictive category, and to help curb the use of illegal opioids in our country. We must act now to stay ahead of the growing number of lives affected by this deadly drug," said Latta.

Background:

Depending on the chemical formulation, some nitazenes can be up to 800 times more potent than morphine and 40 times more potent than fentanyl. Like other illegal street drugs that are often laced with fentanyl, substances may also contain nitazenes without the user's knowledge. According to Medical Discovery News, up to 2,000 people have died from nitazene-related overdoses since 2019. Without greater awareness and education about these substances, that number is expected to grow.

Latta has also championed the HALT Fentanyl Act, which was signed into law on July 16, 2025. The law permanently classifies fentanyl-related substances as Schedule I drugs under the Controlled Substances Act.

Robert E. Latta published this content on March 18, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 18, 2026 at 20:17 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]